272
Participants
Start Date
June 13, 2025
Primary Completion Date
July 26, 2027
Study Completion Date
October 19, 2027
Maridebart cafraglutide
Maridebart cafraglutide will be administered SC.
Placebo
Placebo will be administered SC.
RECRUITING
Meitetsu Hospital, Nagoya
RECRUITING
Hosokawa Surgical Clinic, Nagoya
RECRUITING
Social Medical Corporation Kojunkai Daido Clinic, Nagoya
RECRUITING
Wellness Tenjin Clinic, Fukuoka
RECRUITING
Medical Corporation Boocs Boocs Clinic Fukuoka, Fukuoka
RECRUITING
Kyushu University Hospital, Fukuoka
RECRUITING
Tashiro Endocrinology Clinic, Fukuoka
RECRUITING
Fukuoka Shinmizumaki Hospital, Onga-gun
RECRUITING
Matsunami Health Promotion Clinic, Hashima-gun
RECRUITING
Manda Memorial Hospital, Sapporo
RECRUITING
Yamasaki Family Clinic, Amagasaki-shi
RECRUITING
Kobe University Hospital, Kobe
RECRUITING
Deguchi Clinic, Kobe
RECRUITING
Nishiyamado Keiwa Hospital, Naka
RECRUITING
Aira Diabetes Thyroid Internal Medicine Clinic, Aira-shi
RECRUITING
Matsuba Clinic, Kawasaki-shi
RECRUITING
Medical Corporation Keiseikai Kajiyama Clinic, Kyoto
RECRUITING
Kyoto University Hospital, Kyoto
RECRUITING
Midori Clinic, Nagasaki
RECRUITING
Urasoe General Hospital, Urasoe-shi
RECRUITING
Joh Medical Clinic, Osaka
RECRUITING
Adachi Kyosai Hospital, Adachi-ku
RECRUITING
Nihonbashi Sakura Clinic, Chuo-ku
RECRUITING
Medical Corporation Chiseikai Tokyo Center Clinic, Chuo-ku
RECRUITING
Medical Corporation Kenshinkai Minamino Cardiovascular Hospital, Hachioji-shi
RECRUITING
Tokyo Saiseikai Central Hospital, Minato-ku
RECRUITING
Shimamura Memorial Hospital, Nerima-ku
RECRUITING
MIH Clinic Yoyogi, Shibuya-ku
RECRUITING
Shinjuku Southern Clinic, Shinjuku-ku
RECRUITING
Ikebukuro Metropolitan Clinic, Toshima-ku
Lead Sponsor
Amgen
INDUSTRY